Best Ideas Aren't Always (or Often) From Washington
(8/13, National Pharmaceutical Council: E.V.I.dently Today) comments “In his latest commentary for Chain Drug Review, National Pharmaceutical Council President and CEO Dan Leonard explores the health care concerns and ideas for improvement discussed at recent regional town halls hosted by the Healthcare Leadership Council and NPC.” Full
Best Ideas Aren't Always (Or Often) from Washington
(8/12, Dan Leonard, Chain Drug Review) comments “...Earlier this spring, the National Pharmaceutical Council partnered with the Healthcare Leadership Council to hold town hall meetings in Raleigh, N.C., and Nashville. We asked health care leaders in those communities what really matters to them...One of the key themes that emerged from these town hall conversations is that, while the national conversation has been intensely focused on health care spending, it's more important to focus on getting maximum value for the dollars spent. In fact, sometimes it makes sense to spend more in certain areas, especially when the expenditure serves a public good. This is true for preventive care.” Full
New Research Questions FDA's Reliance on and Inability to Enforce Postmarketing Requirements
(8/13, Zachary Brennan, Regulatory Focus) reports “...And as FDA continues its push toward further using real-world evidence, one current FDA official told [Matthew Herder, director of the Health Law Institute at Dalhousie University]: ‘You just let patients take them, and somehow all of these massive insurance databases will cough up an answer at the end of a year or two about how well the products work and how safe they are. We're not really anywhere near that degree of sophistication in our ability to analyze those big datasets, but there's a huge amount of pressure to push off lots of data collection there without a lot of methodology to do it.’” Full
Datavant, PCORnet to Build Real-World Data Network Spanning 60M Patients
(8/13, Conor Hale, Fierce Biotech) reports “...[PCORnet’s] hundreds of data sets will be able to employ Datavant's token-based ecosystem, which aims to preserve the privacy of patients and study participants while also allowing researchers to share real-world data. Datavant and the [People-Centered Research Foundation] say that unlocking access and merging the findings could create one of the world's richest sources of patient outcomes research.” Full
Assessing Heterogeneity of Treatment Effect Analyses in Health-Related Cluster Randomized Trials: A Systematic Review
Monique Anderson Starks, et al.
August 12, 2019, PLOS One
Assessing Value in Health Care: Using an Interpretive Classification System to Understand Existing Practices Based on a Systematic Review
Brayan V. Seixas, et al.
August 13, 2019, BMC Health Services Research
BMC Health Services Research
Comparative Effectiveness of a Human Fibroblast-Derived Dermal Substitute and a Viable Cryopreserved Placental Membrane for the Treatment of Diabetic Foot Ulcers
Michael L Sabolinski and John V Capotorto
August 13, 2019, Journal of Comparative Effectiveness Research
Journal of Comparative Effectiveness Research
The Potential Impact of CAR T-Cell Treatment Delays on Society
Julia Thornton Snider, PhD, et al.
August 13, 2019, The American Journal of Managed Care